Progression on prevention and treatment of olanzapine in chemotherapy-induced nausea and vomiting
ZHOU Dongai
YI Jun
MA Jin’an
Abstract：Chemotherapy?induced nausea and vomiting is the most common gastrointestinal reaction of chemotherapy side effects, and also one of the important influential factors in chemotherapy compliance within tumor patients. Olanzapine is a widely?used atypical antipsychotics in psychiatric clinical pratice, which also has a ability to block many different antiemetic properties ossociated receptors. In recent years, olanzapine has been approved effectively in the prevention and treatment of chemotherapy?induced nausea and vomiting, with little adverse reaction and good tolerance. This paper summarizes the clnical progression on prevention and treatment of olanzapine in chemotherapy induced nausea and vomiting.
Keywords：OlanzapineChemotherapy-induced nausea and vomiting
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 559-563 )